Rare diseases
Investigational molecules
Locations
Back to Poland93 clinical trials in Zamosc, Poland across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PolandBadaniaKliniczne.pl(opens in a new tab)Study on Burfiralimab for Patients with Moderate to Severe Rheumatoid Arthritis
PolandStudy on the Effects of Guselkumab and Golimumab for Patients with Moderate to Severe Ulcerative Colitis
PolandStudy on the Effectiveness and Safety of Adding Pioglitazone to Metformin and Empagliflozin for Patients with Type 2 Diabetes with Poor Blood Sugar Control
PolandStudy on the Effectiveness and Safety of Guselkumab for Patients with Moderate to Severe Ulcerative Colitis
PolandStudy on the Effectiveness and Safety of Gliclazide MR, Dapagliflozin, and Metformin for Patients with Type 2 Diabetes Not Well Controlled with Dapagliflozin
PolandStudy on Asundexian and Apixaban for Preventing Stroke in Adults with Atrial Fibrillation at Risk for Stroke
PolandStudy on the Effects of Obefazimod for Patients with Moderate to Severe Ulcerative Colitis
PolandStudy on Guselkumab for Healing in Crohn's Disease Patients
PolandStudy of RO7790121 Treatment for Adults with Moderate to Severe Ulcerative Colitis: Testing Effectiveness and Safety in Initial and Long-term Therapy
PolandThe busiest research cities in the country
What the registry says about research in the country
Innovative trials focusing on respiratory infections and prevention strategies, including studies of vaccines against RSV and influenza in older adults.
These studies aim to enhance protection against common respiratory illnesses in vulnerable populations.
Comprehensive research into inflammatory bowel conditions, with multiple trials examining new treatments for Crohn's Disease and Ulcerative Colitis.
Investigations focus on both established and experimental treatments to improve disease management.
Advanced studies targeting atherosclerotic cardiovascular disease and stroke prevention in patients with atrial fibrillation.
Trials evaluate innovative treatments to reduce major adverse cardiovascular events.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
